Enhancement of host defense mechanisms against gram-positive pyogenic coccal infections with levo-tetramisole (levamisole) in neonatal rats.
D000818:Animals; D001419:Bacteria / Q000187:drug effects; D007109:Immunity / Q000187:drug effects*; D007978:Levamisole / Q000494:pharmacology / Q000627:therapeutic use*; D009504:Neutrophils; D010587:Phagocytosis; D010919:Placebos; D051381:Rats; D012867:Skin / Q000473:pathology; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013210:Staphylococcus / Q000187:drug effects; D013290:Streptococcal Infections / Q000188:drug therapy*; D013291:Streptococcus / Q000187:drug effects
D010919:Placebos; D007978:Levamisole